登录 | 注册
一例KCNC2基因突变导致的发育性癫痫性脑病103型患儿的病例报道兼文献复习
A case report and literature review of a child with developmental and epileptic encephalopathy type 103 caused by KCNC2 gene mutation
ES评分 0 浏览量:185 下载量:0
济宁医学院 山东济宁; 济宁医学院附属医院儿科 山东济宁;
[1] Huo L, Wu Q, Yang F, Liu X, Yang Z, Wang H. Novel KCNC2 variant associated with developmental and epileptic encephalopathy. Int J Dev Neurosci. 2023;83(4):357-367.
[2] Clatot J, Currin CB, Liang Q, et al. A structurally precise mechanism links an epilepsy-associated KCNC2 potassium channel mutation to interneuron dysfunction. Proc Natl Acad Sci U S A. 2024;121(3):e2307776121.
[3] Wang S, Yu Y, Wang X, et al. Emerging evidence of genotype-phenotype associations of developmental and epileptic encephalopathy due to KCNC2 mutation: Identification of novel R405G. Front Mol Neurosci. 2022;15:950255. Published 2022 Aug 25.
[4] Li L, Liu Z, Yang H, et al. Investigation of novel de novo KCNC2 variants causing severe developmental and early-onset epileptic encephalopathy. Seizure. 2022;101:218-224.
[5] Seiffert S, Pendziwiat M, Hedrich UBS, Helbig I, Weber Y, Schwarz N. KCNC2 variants of uncertain significance are also associated to various forms of epilepsy. Front Neurol. 2023;14:1212079. Published 2023 Jun 9.
[6] Vetri L, Calì F, Vinci M, et al. A de novo heterozygous mutation in KCNC2 gene implicated in severe developmental and epileptic encephalopathy. Eur J Med Genet. 2020;63(4):103848.
[7] Rydzanicz M, Zwoliński P, Gasperowicz P, et al. A recurrent de novo variant supports KCNC2 involvement in the pathogenesis of developmental and epileptic encephalopathy. Am J Med Genet A. 2021;185(11):3384-3389.
[8] Li P, Butler A, Zhou Y, Magleby KL, Gurnett CA, Salkoff L. Case Report: Targeted treatment by fluoxetine/norfluoxetine of a KCNC2 variant causing developmental and epileptic encephalopathy. Front Pharmacol. 2025;15:1528541. Published 2025 Jan 15.
[9] Schwarz N, Seiffert S, Pendziwiat M, et al. Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants. Neurology. 2022;98(20):e2046-e2059.
[10] Mehinovic E, Gray T, Campbell M, et al. Germline mosaicism of a missense variant in KCNC2 in a multiplex family with autism and epilepsy characterized by long-read sequencing. Am J Med Genet A. 2022;188(7):2071-2081.
[11] Hwang JY, Lee HJ, Go MJ, et al. An integrative study identifies KCNC2 as a novel predisposing factor for childhood obesity and the risk of diabetes in the Korean population. Sci Rep. 2016;6:33043. Published 2016 Sep 14.
[12] Rochtus A, Olson HE, Smith L, et al. Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort. Epilepsia. 2020;61(2):249-258.
[13] Workalemahu T, Clark EAS, Madsen MJ, et al. Mapping genetic susceptibility to spontaneous preterm birth: analysis of Utah pedigrees to find inherited genetic factors. Am J Obstet Gynecol. 2025;232(6):557.e1-557.e10.
[14] Goncharova IA, Zarubin AA, Shipulina SA, et al. Mol Biol (Mosk). 2024;58(3):414-424.
[15] Boda E, Hoxha E, Pini A, Montarolo F, Tempia F. Brain expression of Kv3 subunits during development, adulthood and aging and in a murine model of Alzheimer's disease. J Mol Neurosci. 2012;46(3):606-615.
高群婷, 葛玲, 李秋波, 汤翰林, 徐嘉璇, 郑晨曦, 周扬. 一例KCNC2基因突变导致的发育性癫痫性脑病103型患儿的病例报道兼文献复习 [J]. 国际临床研究杂志. 2026; 10; (3). 81 - 84.
Copyright © 2023 CSCIED科技核心评价数据库 版权所有 京ICP备
Email:info@cscied.com网址:www.cscied.com
互联网出版许可证违法和不良信息举报中心举报邮箱:jubao@cscied.com